Orthofix Investor Presentation Deck

Diversified & Strategic Business Mix in Growing Markets 40% Orthofix $463M * 23% 24% ORTHOFIX® 13% 56% SeaSpine $230M* 44% Bone Growth Therapies Spinal Implants + Enabling Tech. SeaSpine. *LTM revenue as of September 30, 2022 Biologics Orthopedics Combined Company 27% 15% $693 M* 23% 35% 14

View entire presentation